Register

SmallMolecules.com > Supplier: LKT Laboratories, Inc.

LKT Laboratories, Inc.

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Ciglitazone 5 mg | ≥98%

LKT Laboratories, Inc.

Thiazolidinedione; PPARγ agonist.

More Information Supplier Page

Ciglitazone 25 mg | ≥98%

LKT Laboratories, Inc.

Thiazolidinedione; PPARγ agonist.

More Information Supplier Page

Cilnidipine 100 mg | ≥98%

LKT Laboratories, Inc.

Dihydropyridine; L-type and N-type Ca2+ channel blocker.

More Information Supplier Page

Cilnidipine 250 mg | ≥98%

LKT Laboratories, Inc.

Dihydropyridine; L-type and N-type Ca2+ channel blocker.

More Information Supplier Page

Cilnidipine 1 g | ≥98%

LKT Laboratories, Inc.

Dihydropyridine; L-type and N-type Ca2+ channel blocker.

More Information Supplier Page

Cilostazol 50 mg | ≥98%

LKT Laboratories, Inc.

Quinoline; PDE 3B inhibitor.

More Information Supplier Page

Cilostazol 100 mg | ≥98%

LKT Laboratories, Inc.

Quinoline; PDE 3B inhibitor.

More Information Supplier Page

Cilostazol 500 mg | ≥98%

LKT Laboratories, Inc.

Quinoline; PDE 3B inhibitor.

More Information Supplier Page

Cimetidine 5 g | ≥98%

LKT Laboratories, Inc.

Histamine H2 and AR antagonist, catalase inhibitor.

More Information Supplier Page

Cimetidine 10 g | ≥98%

LKT Laboratories, Inc.

Histamine H2 and AR antagonist, catalase inhibitor.

More Information Supplier Page

Cimetidine 25 g | ≥98%

LKT Laboratories, Inc.

Histamine H2 and AR antagonist, catalase inhibitor.

More Information Supplier Page

Cinnarizine 10 g | ≥98%

LKT Laboratories, Inc.

FIASMA, L-type Ca2+ channel blocker, D2 antagonist.

More Information Supplier Page

Cinnarizine 100 g | ≥98%

LKT Laboratories, Inc.

FIASMA, L-type Ca2+ channel blocker, D2 antagonist.

More Information Supplier Page

Ciprofibrate 25 mg | ≥98%

LKT Laboratories, Inc.

Fibrate; PPARα agonist.

More Information Supplier Page

Ciprofibrate 100 mg | ≥98%

LKT Laboratories, Inc.

Fibrate; PPARα agonist.

More Information Supplier Page

Ciprofloxacin 5 g | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; topoisomerase IV and bacterial DNA gyrase inhibitor.

More Information Supplier Page

Ciprofloxacin 25 g | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; topoisomerase IV and bacterial DNA gyrase inhibitor.

More Information Supplier Page

Ciprofloxacin 50 g | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; topoisomerase IV and bacterial DNA gyrase inhibitor.

More Information Supplier Page

Ciprofloxacin Hydrochloride Monohydrate 5 g | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; topoisomerase IV and bacterial DNA gyrase inhibitor.

More Information Supplier Page

Ciprofloxacin Hydrochloride Monohydrate 25 g | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; topoisomerase IV and bacterial DNA gyrase inhibitor.

More Information Supplier Page

Ciprofloxacin Hydrochloride Monohydrate 50 g | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; topoisomerase IV and bacterial DNA gyrase inhibitor.

More Information Supplier Page

Cisatracurium Besylate 25 mg | ≥95%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR and M2 mAChR antagonist.

More Information Supplier Page

Cisatracurium Besylate 100 mg | ≥95%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR and M2 mAChR antagonist.

More Information Supplier Page

Cisatracurium Besylate 500 mg | ≥95%

LKT Laboratories, Inc.

Non-depolarizing NMJ blocker; nAChR and M2 mAChR antagonist.

More Information Supplier Page

Cisplatin 50 mg | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

Cisplatin 100 mg | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

Cisplatin 500 mg | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

Cisplatin 1 g | ≥98%

LKT Laboratories, Inc.

Pt-based DNA cross-linker.

More Information Supplier Page

Citalopram Hydrobromide 25 mg | ≥98%

LKT Laboratories, Inc.

SERT inhibitor.

More Information Supplier Page

Citalopram Hydrobromide 100 mg | ≥98%

LKT Laboratories, Inc.

SERT inhibitor.

More Information Supplier Page

Citalopram Hydrobromide 500 mg | ≥98%

LKT Laboratories, Inc.

SERT inhibitor.

More Information Supplier Page

Citreoviridin A 1 mg | ≥95%

LKT Laboratories, Inc.

Mycotoxin; F1F0 ATP synthase inhibitor.

More Information Supplier Page

Citreoviridin A 5 mg | ≥95%

LKT Laboratories, Inc.

Mycotoxin; F1F0 ATP synthase inhibitor.

More Information Supplier Page

Citrinin 5 mg | ≥98%

LKT Laboratories, Inc.

Mycotoxin produced by Penicillum, Aspergillus, and Monascus.

More Information Supplier Page

Citrinin 5 mg | ≥98%

LKT Laboratories, Inc.

Mycotoxin produced by Penicillum, Aspergillus, and Monascus.

More Information Supplier Page

Citrinin 10 mg | ≥98%

LKT Laboratories, Inc.

Mycotoxin produced by Penicillum, Aspergillus, and Monascus.

More Information Supplier Page

CKS-17 1 mg | ≥95%

LKT Laboratories, Inc.

Synthetic peptide, retroviral envelope protein sequence analog.

More Information Supplier Page

CKS-17 0.5 mg | ≥95%

LKT Laboratories, Inc.

Synthetic peptide, retroviral envelope protein sequence analog.

More Information Supplier Page

CKS-17 2.5 mg | ≥95%

LKT Laboratories, Inc.

Synthetic peptide, retroviral envelope protein sequence analog.

More Information Supplier Page

Cladribine 5 mg | ≥98%

LKT Laboratories, Inc.

Nucleoside (deoxyadenosine) analog; DNA chain terminator, ribonucleotide reductase and DNA polymerase inhibitor.

More Information Supplier Page

Cladribine 10 mg | ≥98%

LKT Laboratories, Inc.

Nucleoside (deoxyadenosine) analog; DNA chain terminator, ribonucleotide reductase and DNA polymerase inhibitor.

More Information Supplier Page

Cladribine 25 mg | ≥98%

LKT Laboratories, Inc.

Nucleoside (deoxyadenosine) analog; DNA chain terminator, ribonucleotide reductase and DNA polymerase inhibitor.

More Information Supplier Page

Clarithromycin 100 mg | ≥95%

LKT Laboratories, Inc.

Macrolide; protein translation inhibitor.

More Information Supplier Page

Clarithromycin 250 mg | ≥95%

LKT Laboratories, Inc.

Macrolide; protein translation inhibitor.

More Information Supplier Page

Clarithromycin 1 g | ≥95%

LKT Laboratories, Inc.

Macrolide; protein translation inhibitor.

More Information Supplier Page

Clenbuterol Hydrochloride 25 mg | ≥98%

LKT Laboratories, Inc.

β2-adrenergic agonist.

More Information Supplier Page

Clenbuterol Hydrochloride 100 mg | ≥98%

LKT Laboratories, Inc.

β2-adrenergic agonist.

More Information Supplier Page

Clenbuterol Hydrochloride 250 mg | ≥98%

LKT Laboratories, Inc.

β2-adrenergic agonist.

More Information Supplier Page

Climbazole 5 g | ≥98%

LKT Laboratories, Inc.

14-α demethylase inhibitor.

More Information Supplier Page

Climbazole 10 g | ≥98%

LKT Laboratories, Inc.

14-α demethylase inhibitor.

More Information Supplier Page